المؤلفون: Van Cutsem, E, Cervantes, A, Adam, R, Sobrero, A, Van Krieken, J H, Aderka, D, Aranda Aguilar, E, Bardelli, A, Benson, A, Bodoky, G, Ciardiello, F, D'Hoore, A, Diaz-Rubio, E, Douillard, J-Y, Ducreux, M, Falcone, A, Grothey, A, Gruenberger, T, Haustermans, K, Heinemann, V, Hoff, P, Köhne, C-H, Labianca, R, Laurent-Puig, P, Ma, B, Maughan, T, Muro, K, Normanno, N, Österlund, P, Oyen, W J G, Papamichael, D, Pentheroudakis, G, Pfeiffer, P, Price, T J, Punt, C, Ricke, J, Roth, A, Salazar, R, Scheithauer, W, Schmoll, H J, Tabernero, J, Taïeb, J, Tejpar, S, Wasan, H, Yoshino, T, Zaanan, A, Arnold, D

مصطلحات موضوعية: ESMO, clinical practice guidelines, colorectal cancer, consensus, Biomarkers, Tumor, Colorectal Neoplasms, Guidelines as Topic, Humans, Molecular Targeted Therapy, Neoplasm Metastasis, Prognosis

العلاقة: http://hdl.handle.net/10668/10243Test; https://doi.org/10.1093/annonc/mdw235Test

الإتاحة: https://doi.org/10.1093/annonc/mdw235Test
http://hdl.handle.net/10668/10243Test

المؤلفون: Ameri, P, Canepa, M, Anker, MS, Belenkov, Y, Bergler-Klein, J, Cohen-Solal, A, Farmakis, D, López-Fernández, T, Lainscak, M, Pudil, R, Ruschitska, F, Seferovic, P, Filippatos, G, Coats, A, Suter, T, Von Haehling, S, Ciardiello, F, De Boer, RA, Lyon, AR, Tocchetti, CG, Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology

المساهمون: Ameri, Pietro, Canepa, Marco, Anker, Markus S., Belenkov, Yury, Bergler-Klein, Jutta, Cohen-Solal, Alain, Farmakis, Dimitrio, López-Fernández, Teresa, Lainscak, Mitja, Pudil, Radek, Ruschitska, Frank, Seferovic, Petar, Filippatos, Gerasimo, Coats, Andrew, Suter, Thoma, Von Haehling, Stephan, Ciardiello, Fortunato, de Boer, Rudolf A., Lyon, Alexander R., Tocchetti, Carlo G.

المصدر: European Journal of Heart Failure. 20(5):879-887

مصطلحات موضوعية: Cardiac & Cardiovascular Systems, medicine.medical_treatment, Co-morbidity, Comorbidity, 030204 cardiovascular system & hematology, Global Health, Targeted therapy, Androgen deprivation therapy, Prostate cancer, 0302 clinical medicine, TARGETED THERAPY, RENAL-CELL CARCINOMA, Neoplasms, Epidemiology, INCREASED RISK, AMERICAN SOCIETY, Cancer, Heart failure, Prognosis, Therapy, Cardiology and Cardiovascular Medicine, ORAL ANTICOAGULANTS, Incidence (epidemiology), Incidence, Disease Management, 3. Good health, PROSTATE-CANCER, Survival Rate, PRACTICE GUIDELINES, 030220 oncology & carcinogenesis, Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology, Life Sciences & Biomedicine, Diagnostic Imaging, medicine.medical_specialty, Prognosi, LONG-TERM, Malignancy, 1102 Cardiovascular Medicine And Haematology, 03 medical and health sciences, Breast cancer, medicine, Humans, BREAST-CANCER, Intensive care medicine, TERM-FOLLOW-UP, EUROPEAN ASSOCIATION, Science & Technology, business.industry, medicine.disease, MYOCARDIAL-INFARCTION, Cardiovascular System & Hematology, ATRIAL-FIBRILLATION, Cardiovascular System & Cardiology, ANDROGEN DEPRIVATION THERAPY, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4ae5221f0ca1c551bc118d061e00b74Test
https://hdl.handle.net/11370/4cad5946-19a3-4022-8749-fb5e2127683fTest

المؤلفون: Della Corte CM, Viscardi G, Papaccio F, Esposito G, Martini G, Ciardiello D, Martinelli E, Ciardiello F, Morgillo F.

المساهمون: Della Corte, Cm, Viscardi, G, Papaccio, F, Esposito, G, Martini, G, Ciardiello, D, Martinelli, E, Ciardiello, F, Morgillo, F.

مصطلحات موضوعية: Hedgehog, Epithelial-mesenchymal transition, Hepatocellular carcinoma, Hepatocarcinogenesi, Prognosis

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28706416; info:eu-repo/semantics/altIdentifier/wos/WOS:000405228300003; volume:23(24); firstpage:4330; lastpage:4340; numberofpages:11; journal:WORLD JOURNAL OF GASTROENTEROLOGY; https://hdl.handle.net/11386/4752917Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85021356500; https://www.wjgnet.com/1007-9327/full/v23/i24/4330.htmTest

الإتاحة: https://doi.org/10.3748/wjg.v23.i24.4330Test
https://hdl.handle.net/11386/4752917Test
https://www.wjgnet.com/1007-9327/full/v23/i24/4330.htmTest

المؤلفون: Peters, S., Stahel, R.A., Dafni, U., Ponce Aix, S., Massutí, B., Gautschi, O., Coate, L., López Martín, A., van Heemst, R., Berghmans, T., Meldgaard, P., Cobo Dols, M., Garde Noguera, J., Curioni-Fontecedro, A., Rauch, D., Mark, M.T., Cuffe, S., Biesma, B., van Henten, AMJ, Juan Vidal, Ó., Palmero Sanchez, R., Villa Guzmán, J.C., Collado Martin, R., Peralta, S., Insa, A., Summers, Y., Láng, I., Horgan, A., Ciardiello, F., de Hosson, S., Pieterman, R., Groen, HJM, van den Berg, P.M., Zielinski, C.C., Chittazhathu Kurian Kuruvilla, Y., Gasca-Ruchti, A., Kassapian, M., Novello, S., Torri, V., Tsourti, Z., Gregorc, V., Smit, E.F.

المساهمون: EMPHASIS-lung Collaborative Group

المصدر: Journal of thoracic oncology, vol. 12, no. 4, pp. 752-762

مصطلحات موضوعية: Aged, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carcinoma, Non-Small-Cell Lung/drug therapy, Non-Small-Cell Lung/pathology, Squamous Cell/drug therapy, Squamous Cell/pathology, Cohort Studies, Erlotinib Hydrochloride/administration & dosage, Female, Follow-Up Studies, Humans, Lung Neoplasms/drug therapy, Lung Neoplasms/pathology, Male, Neoplasm Staging, Platinum/administration & dosage, Prognosis, Survival Rate, Taxoids/administration & dosage, Docetaxel, ETOP, Erlotinib, NSCLC, Squamous, VeriStrat

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28017787; info:eu-repo/semantics/altIdentifier/eissn/1556-1380; https://serval.unil.ch/notice/serval:BIB_D30A1C513C0CTest; urn:issn:1556-0864

الإتاحة: https://doi.org/10.1016/j.jtho.2016.12.017Test
https://serval.unil.ch/notice/serval:BIB_D30A1C513C0CTest

المؤلفون: Peters S, Stahel RA, Dafni U, Ponce Aix S, Massutí B, Gautschi O, Coate L, López Martín A, van Heemst R, Berghmans T, Meldgaard P, Cobo Dols M, Garde Noguera J, Curioni-Fontecedro A, Rauch D, Mark MT, Cuffe S, Biesma B, van Henten AMJ, Juan Vidal Ó, Palmero Sanchez R, Villa Guzmán JC, Collado Martin R, Peralta S, Insa A, Summers Y, Láng I, Horgan A, Ciardiello F, de Hosson S, Pieterman R, Groen HJM, van den Berg PM, Zielinski CC, Chittazhathu Kurian Kuruvilla Y, Gasca-Ruchti A, Kassapian M, Novello S, Torri V, Tsourti Z, Gregorc V, Smit EF, EMPHASIS-lung Collaborative Group

المساهمون: Pulmonary medicine, CCA - Cancer Treatment and quality of life, Peters, S, Stahel, Ra, Dafni, U, Aix, Sp, Massutí, B, Gautschi, O, Coate, L, López Martín, A, Van Heemst, R, Berghmans, T, Meldgaard, P, Cobo Dols, M, Noguera, Jg, Curioni Fontecedro, A, Rauch, D, Mark, Mt, Cuffe, S, Biesma, B, Van Henten, Am, Vidal, Ój, Sanchez, Rp, Villa Guzmán, Jc, Martin, Rc, Peralta, S, Insa, A, Summers, Y, Láng, I, Horgan, A, Ciardiello, Fortunato, De Hosson, S, Pieterman, R, Groen, Hj, Van Den Berg, Pm, Zielinski, Cc, Kuruvilla, Yc, Gasca Ruchti, A, Kassapian, M, Novello, S, Torri, V, Tsourti, Z, Gregorc, V, Smit, Ef, EMPHASIS lung collaborative, Group

المصدر: JOURNAL OF THORACIC ONCOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Journal of Thoracic Oncology, 12(4), 752-762. International Association for the Study of Lung Cancer
Peters, S, Stahel, R A, Dafni, U, Ponce Aix, S, Massutí, B, Gautschi, O, Coate, L, López Martín, A, van Heemst, R, Berghmans, T, Meldgaard, P, Cobo Dols, M, Garde Noguera, J, Curioni-Fontecedro, A, Rauch, D, Mark, M T, Cuffe, S, Biesma, B, van Henten, A M J, Juan Vidal, Ó, Palmero Sanchez, R, Villa Guzmán, J C, Collado Martin, R, Peralta, S, Insa, A, Summers, Y, Láng, I, Horgan, A, Ciardiello, F, de Hosson, S, Pieterman, R, Groen, H J M, van den Berg, P M, Zielinski, C C, Chittazhathu Kurian Kuruvilla, Y, Gasca-Ruchti, A, Kassapian, M, Novello, S, Torri, V, Tsourti, Z, Gregorc, V, Smit, E F & EMPHASIS-lung Collaborative Group 2017, ' Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial ', Journal of Thoracic Oncology, vol. 12, no. 4, pp. 752-762 . https://doi.org/10.1016/j.jtho.2016.12.017Test
Peters, S, Stahel, R A, Dafni, U, Ponce Aix, S, Massutí, B, Gautschi, O, Coate, L, López Martín, A, van Heemst, R, Berghmans, T, Meldgaard, P, Cobo Dols, M, Garde Noguera, J, Curioni-Fontecedro, A, Rauch, D, Mark, M T, Cuffe, S, Biesma, B, van Henten, A M J, Juan Vidal, Ó, Palmero Sanchez, R, Villa Guzmán, J C, Collado Martin, R, Peralta, S, Insa, A, Summers, Y, Láng, I, Horgan, A, Ciardiello, F, de Hosson, S, Pieterman, R, Groen, H J M, van den Berg, P M, Zielinski, C C, Chittazhathu Kurian Kuruvilla, Y, Gasca-Ruchti, A, Kassapian, M, Novello, S, Torri, V, Tsourti, Z, Gregorc, V, Smit, E F & EMPHASIS-lung Collaborative Group 2017, ' Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial ', Journal of Thoracic Oncology, vol. 12, no. 4, pp. 752-762 . https://doi.org/10.1016/j.jtho.2016.12.017Test
Journal of Thoracic Oncology, 12(4), 752-762. ELSEVIER SCIENCE INC

مصطلحات موضوعية: Oncology, Male, Lung Neoplasms, medicine.medical_treatment, Docetaxel, NSCLC, THERAPY, Squamous, Cohort Studies, RETROSPECTIVE ANALYSIS, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, 3RD-LINE, Antineoplastic Combined Chemotherapy Protocols, VeriStrat, 030212 general & internal medicine, Erlotinib Hydrochloride, ETOP, Prognosis, Survival Rate, Erlotinib, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Female, Taxoids, Veristrat, 2ND-LINE TREATMENT, medicine.drug, Pulmonary and Respiratory Medicine, medicine.medical_specialty, 03 medical and health sciences, Internal medicine, Multicenter trial, medicine, TYROSINE KINASE INHIBITORS, Journal Article, Humans, Lung cancer, COMBINATION, Survival rate, neoplasms, METAANALYSIS, Aged, Neoplasm Staging, Platinum, Chemotherapy, business.industry, medicine.disease, respiratory tract diseases, business, GROWTH-FACTOR RECEPTOR, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee1d367d8bc33b24edc27d000909d5bdTest
https://pubmed.ncbi.nlm.nih.gov/28343541Test

المؤلفون: Di Maio, M, Leighl, Nb, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, Ms, Signoriello, S, Perrone, F, Gridelli, C, Torch, Investigators, Calabro', L

المساهمون: Di Maio, M., Leighl, N. B., Gallo, C., Feld, R., Ciardiello, F., Butts, C., Maione, P., Gebbia, V., Morgillo, F., Wierzbicki, R., Favaretto, A., Alam, Y., Cinieri, S., Siena, S., Bianco, Roberto, Riccardi, F., Spatafora, M., Ravaioli, A., Felletti, R., Fregoni, V., Genestreti, G., Rossi, A., Mancuso, G., Fasano, M., Morabito, A., Tsao, M. S., Signoriello, S., Perrone, F., Gridelli, C., Di Maio, M, Leighl, N, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, M, Signoriello, S, Perrone, F, Gridelli, C, Leighl, Nb

مصطلحات موضوعية: Oncology, Male, erlotinib, Lung Neoplasms, Health-related quality of life, NSCLC, chemotherapy, Deoxycytidine, law.invention, Randomized controlled trial, Quality of life, law, Carcinoma, Non-Small-Cell Lung, Surveys and Questionnaires, Antineoplastic Combined Chemotherapy Protocols, Surveys and Questionnaire, Quality of life analysis of TORCH, Erlotinib Hydrochloride, Prognosis, humanities, Research Design, Advanced non–small-cell lung cancer, Carcinoma, Squamous Cell, Female, Erlotinib, Randomized trial, medicine.drug, Human, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Prognosi, EGFR, First-line treatment, first-line erlotinib, second-line cisplatin/gemcitabine chemotherapy, Adenocarcinoma, NO, Follow-Up Studie, Internal medicine, advanced non-small-cell lung cancer, medicine, Humans, Lung cancer, Advanced non-small-cell lung cancer, Chemotherapy, Quality of life analysis of TORCH , first-line erlotinib , second-line cisplatin/gemcitabine chemotherapy, advanced non-small-cell lung cancer, Aged, Neoplasm Staging, Salvage Therapy, Antineoplastic Combined Chemotherapy Protocol, business.industry, Questionnaire, Cancer, Quinazoline, medicine.disease, Interim analysis, Gemcitabine, Surgery, Lung Neoplasm, quality of life, Quinazolines, Carcinoma, Large Cell, Cisplatin, Neoplasm Recurrence, Local, business, Follow-Up Studies

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::297e0496785c9c52225a929dbddaa27eTest
http://hdl.handle.net/11588/519780Test

المؤلفون: Cutsem, E. Van, Dicato, M., Arber, N., Berlin, J., Cervantes, A., Ciardiello, F., Gramont, A. De, Diaz-Rubio, E., Ducreux, M., Geva, R., Glimelius, B., Glynne-Jones, R., Grothey, Axel, Gruenberger, T., Haller, D., Haustermans, K., Labianca, R., Lenz, H. J., Minsky, B., Nordlinger, B., Ohtsu, A., Pavlidis, Nicholas, Rougier, P., Schmiegel, W., Velde, C. Van de, Schmoll, H. J., Sobrero, A., Tabernero, Josep

المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961]

المصدر: Annals of Oncology : Official Journal of the European Society for Medical Oncology / ESMO

مصطلحات موضوعية: Oncology, Colorectal cancer, medicine.medical_treatment, Braf protein, Gastroenterology, Metastasis, Drug antagonism, Targeted therapy, Antineoplastic agents, Pathology, Conference paper, Biological markers, Predictive marker, Hematology, Prognosis, Chemotherapy regimen, Antineoplastic agent, Proto-oncogene proteins, Ras protein, Human, Receptor, medicine.medical_specialty, Neoplasm metastasis, Ras proteins, MEDLINE, Oncoprotein, Colorectal neoplasms, Proto-oncogene proteins b-raf, Internal medicine, Genetics, medicine, Humans, Gastrointestinal cancer, Colorectal tumor, B raf kinase, Epidermal growth factor receptor, Kras protein, business.industry, Epidermal growth factor, Cancer, medicine.disease, digestive system diseases, Biological marker, Metabolism, Spain, Mutation, Carcinoembryonic antigen, Microsatellite instability, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbacd7b9ee1ebf6fa145eb7d60aaa564Test
https://doi.org/10.1093/annonc/mdq273Test

المؤلفون: Ventriglia, J., Petrillo, A., Huerta Alváro, M., Laterza, M. M., Savastano, B., Gambardella, V., Tirino, G., Pompella, L., Diana, A., Iovino, F., Troiani, T., Martinelli, E., Morgillo, F., Orditura, M., Cervantes, A., Ciardiello, F., De Vita, F.

المصدر: Gastroenterology Research & Practice; 6/10/2018, p1-7, 7p

مصطلحات موضوعية: PANCREATIC cancer treatment, PANCREATIC cancer, NEUTROPHILS, LYMPHOCYTES, PACLITAXEL, PROGNOSIS

المؤلفون: Bourhis, J., Stein, A., Paul de Boer, J., Van Den Eynde, M., Gold, K.A., Stintzing, S., Becker, J.C., Moran, M., Schroeder, A., Pennock, G., Salmio, S., Esser, R., Ciardiello, F.

المصدر: Cancer treatment reviews, vol. 97, pp. 102172

مصطلحات موضوعية: Antibodies, Monoclonal, Humanized/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Cetuximab/administration & dosage, Clinical Trials as Topic, Humans, Neoplasms/drug therapy, Neoplasms/pathology, Prognosis, Anti–PD-L1, Avelumab, Cetuximab, Combination therapy, anti-EGFR

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33989949; info:eu-repo/semantics/altIdentifier/eissn/1532-1967; https://serval.unil.ch/notice/serval:BIB_90CC642BEF44Test; urn:issn:0305-7372

الإتاحة: https://doi.org/10.1016/j.ctrv.2021.102172Test
https://serval.unil.ch/notice/serval:BIB_90CC642BEF44Test

المؤلفون: Van Cutsem, E., Dicato, M., Arber, N., Berlin, J., Cervantes, A., Ciardiello, F., De Gramont, A., Diaz-Rubio, E., Ducreux, M., Geva, R., Glimelius, B., Glynne Jones, R., Grothey, A., Gruenberger, T., Haller, D., Haustermans, K., Labianca, R., Lenz, H. J., Minsky, B., Nordlinger, B., Ohtsu, A., Pavlidis, N., Rougier, P., Schmiegel, W., Van de Velde, C., Schmoll, H. J., Sobrero, A., Tabernero, J.

مصطلحات موضوعية: Antineoplastic Agents/adverse effects, Biological Markers/metabolism, Carcinoembryonic Antigen/analysis, Colorectal Neoplasms/*drug therapy/genetics/pathology, Humans, Microsatellite Instability, Mutation, Neoplasm Metastasis, Prognosis, Proto-Oncogene Proteins/genetics, Proto-Oncogene Proteins B-raf/genetics, Receptor, Epidermal Growth Factor/antagonists & inhibitors, Spain, ras Proteins/genetics

العلاقة: http://olympias.lib.uoi.gr/jspui/handle/123456789/19956Test

الإتاحة: http://olympias.lib.uoi.gr/jspui/handle/123456789/19956Test